Document Environmental and Social Sustainability

Statement with EFORT on cobalt in orthopaedic implants

MedTech Europe’s Orthopaedic Sector Group adopted a joint statement with EFORT, the European Federation of National Associations of Orthopaedics and Traumatology, on the use of cobalt in orthopaedic implants.

Under the new EU Medical Devices Regulation 745/2017, various medical devices that continue containing cobalt will very likely need to comply with new obligations – notably, they will need to indicate on the device or label that cobalt (a purportedly ‘cancer-causing’ substance) is present.

The statement aims at reassuring patients and healthcare professionals that the presence of cobalt in these implants – and the communication of this on the device/label – is no cause for safety concerns, and does not change these products’ long history of safe clinical use.

Posted on 04.10.2018

Related content

News Environment & Medical Technology Environmental and Social Sustainability Newsletter

ECHA looks at authorization for Tritons in medtech

Posted on 06.12.2018

Read more
Blog Environmental and Social Sustainability

How Public Procurement can Drive More Sustainable Healthcare

Posted on 25.10.2018

Read more